Medical, Legal, And Practice
Bayer reports results of phase II gadoquatrane clinical trial at RSNA
Bayer presented positive results of its phase II clinical trial of macrocyclic gadolinium-based compound gadoquatraine in a scientific session at RSNA 2023.
November 29, 2023
PET tracer shows promise in prostate cancer patients
Gallium-68 RM2-PET/MRI is better than MRI alone for detecting relapse in prostate cancer patients, researchers have told attendees at RSNA 2023.
November 27, 2023
Advanced imaging comes of age in brain cancer treatment
The use of advanced imaging techniques in brain cancer treatment is evolving fast, particularly in evaluating the use of radiotracers in glioblastoma cases, a new study shows.
November 22, 2023
FAPI-PET shows promise for detecting pancreatic cancer
FAPI-PET imaging looks set to become a powerful diagnostic tool for detecting pancreatic cancer. That's the view of authors from University Hospital Essen in Germany.
November 21, 2023
Team Parizel/Francis opens imaging facility in Western Australia
ESR past president Prof. Paul Parizel, PhD, nuclear medicine physician Ros Francis, PhD, and colleagues have opened an advanced imaging facility in Western Australia. Over 200 people attended the recent official launch event.
November 8, 2023
German study shines light on optimum use of PET in Alzheimer's
A research group at the University of Munich has used PET imaging to reveal brain pathology linked to faster clinical progression of Alzheimer’s disease in patients with ApoE4 gene variants.
November 8, 2023
EANM restructures and revises statutes
The European Association of Nuclear Medicine (EANM) has updated and revised its statutes to reflect the evolving needs of the association's membership.
November 5, 2023
United installs PET/CT scanner in Bologna
United Imaging Healthcare Europe has highlighted that the St. Orsola University Hospital in Bologna, Italy, is integrating the company's uMI Vista PET/CT system into the facility's medical oncology unit.
October 26, 2023
Pediatric PET radiotracer doses drop by a third over two decades
Over the past 20 years, children have benefited from a massive reduction in PET imaging radiotracer doses without compromising image quality, according to researchers in Switzerland.
October 22, 2023
Does a novel PET system for prostate cancer have real clinical potential?
A recently built dedicated PET scanner may improve the detection of prostate cancer and could ultimately reduce invasive patient biopsies to confirm disease, according to a research team in Bologna, Italy.
October 15, 2023
GE HealthCare and Sofie sign deal to develop FAPI-PET tracers
GE HealthCare has established a licensing agreement to commercialize two fibroblast activated protein inhibitor (FAPI)-PET radiotracers developed by Sofie Biosciences for cancer imaging.
October 12, 2023
Nobel Prize goes to Moungi Bawendi for imaging innovation
Moungi Bawendi, PhD, is one of three scientists to share the Nobel Prize in Chemistry in recognition of the discovery and synthesis of quantum dots. Bawendi is a co-founder of Lumicell, which develops fluorescence-guided imaging technology for cancer surgery.
October 8, 2023
Page 1 of 113